David Nutt

NeuroscienceMedicinePsychology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

2in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Why this DataRank?

An author's DataRank is the sum of the DataRanks of all 2 indexed papers attributed to them. A prolific author with many moderate-impact papers can outrank one with a single high-impact paper.

Author scores recompute whenever paper DataRanks are refreshed, so this number lags the underlying paper scores by at most one batch run.

Read the full methodology →

Papers

Driven by 9 papers. Top paper: “The difference between ‘placebo group’ and ‘placebo control’: a case study in psychedelic microdosing”.

The difference between ‘placebo group’ and ‘placebo control’: a case study in psychedelic microdosing

Scientific Reports(2023)10.1038/s41598-023-34938-7

N/A

0.533DataRank · unranked

34 citations

David Nutt, Robin Carhart-Harris, David Erritzoe, Balázs Szigeti

Prescribed Medical Cannabis Use Among Older Individuals: Patient Characteristics and Improvements in Well-Being: Findings from T21

Drugs & Aging(2024)10.1007/s40266-024-01123-y

N/A

0.269DataRank · unranked

5 citations

Hannah Thurgur, Alkyoni Athanasiou-Fragkouli, Anne K. Schlag, David Nutt, Michael T. Lynskey

LSD and psilocybin flatten the brain’s energy landscape: insights from receptor-informed network control theory

bioRxiv (Cold Spring Harbor Laboratory)(2021)10.1101/2021.05.14.444193

N/A

0DataRank · unranked

30 citations

Andrea I. Luppi, Robin Carhart‐Harris, Josephine Cruzat, Leor Roseman, David Nutt +5 more

Receptor-informed network control theory links LSD and psilocybin to a flattening of the brain’s control energy landscape

Nature Communications(2022)10.1038/s41467-022-33578-1

N/A

0DataRank · unranked

157 citations

Andrea I. Luppi, Robin Carhart‐Harris, Josephine Cruzat, Leor Roseman, David Nutt +5 more

A Delphi-method-based consensus guideline for definition of treatment-resistant depression for clinical trials

Molecular Psychiatry(2021)10.1038/s41380-021-01381-x

N/A

0DataRank · unranked

204 citations

Courtney Worrell, Melisa Kose, Ian Anderson, Bruno Aouizerate, Volker Arolt +56 more

A leaky umbrella has little value: evidence clearly indicates the serotonin system is implicated in depression

Molecular Psychiatry(2023)10.1038/s41380-023-02095-y

N/A

0DataRank · unranked

75 citations

Danilo Arnone, David S. Baldwin, Michael Bloomfield, Michael Browning, Anthony J. Cleare +30 more

Assessing the risk of symptom worsening in psilocybin-assisted therapy for depression: A systematic review and individual participant data meta-analysis

Psychiatry Research(2023)10.1016/j.psychres.2023.115349

N/A

0DataRank · unranked

24 citations

Per Carlbring, Robin Carhart‐Harris, Alan K. Davis, David Nutt, Roland R. Griffiths +3 more

Relationship between astrocyte reactivity, using novel 11C-BU99008 PET, and glucose metabolism, grey matter volume and amyloid load in cognitively impaired individuals

Molecular Psychiatry(2022)10.1038/s41380-021-01429-y

N/A

0DataRank · unranked

41 citations

Valeria Calsolaro, Rainer Hinz, Joseph Nowell, Sanara Raza, Steve Gentleman +13 more

Astrocyte reactivity with late-onset cognitive impairment assessed in vivo using 11C-BU99008 PET and its relationship with amyloid load

Molecular Psychiatry(2021)10.1038/s41380-021-01193-z

N/A

0DataRank · unranked

63 citations

Paul M. Matthews, Cornelius K. Donat, Nicholas R Livingston, Grazia Daniela Femminella, Sandra Silva Guedes +16 more